WARFARIN PLUS SULFONYLUREAS AND SERIOUS HYPOGLYCEMIC EVENTS Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas

被引：1
作者：
Bosco-Levy, Pauline [1 ]
Salvo, Francesco [1 ]
机构：
[1] Univ Bordeaux, UMR1219, CHU Bordeaux, 146 Rue Leo Saignat, F-33076 Bordeaux, France
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2016年 / 354卷
关键词：
ANTIDIABETIC DRUGS;
D O I：
10.1136/bmj.i4328
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 5 条
  • [1] Use of Antidiabetic Drugs in the U. S., 2003-2012
    Hampp, Christian
    Borders-Hemphill, Vicky
    Moeny, David G.
    Wysowski, Diane K.
    [J]. DIABETES CARE, 2014, 37 (05) : 1367 - 1374
  • [2] Clinically and pharmacologically relevant interactions of antidiabetic drugs
    May, Marcus
    Schindler, Christoph
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2016, 7 (02) : 69 - 83
  • [3] Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
    Nutescu, Edith
    Chuatrisorn, Ittiporn
    Hellenbart, Erika
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 326 - 343
  • [4] Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis
    Romley, John A.
    Gong, Cynthia
    Jena, Anupam B.
    Goldman, Dana P.
    Williams, Bradley
    Peters, Anne
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [5] Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001
    Wysowski, DK
    Armstrong, G
    Governale, L
    [J]. DIABETES CARE, 2003, 26 (06) : 1852 - 1855
1